Munich - Delayed Quote • EUR HarborOne Bancorp Inc (1S4.MU) Follow Add holdings 10.00 +0.05 +(0.50%) At close: May 28 at 8:02:57 AM GMT+2 All News Press Releases SEC Filings Exploring 3 Undiscovered Gems in the US Market Over the last 7 days, the United States market has experienced a 2.7% drop, although it has risen by 9.1% over the past year with earnings forecasted to grow by 14% annually. In this dynamic environment, identifying stocks that are not only resilient but also poised for future growth can be key to uncovering potential opportunities in the market. Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. Q1 Earnings Highlights: STERIS (NYSE:STE) Vs The Rest Of The Surgical Equipment & Consumables - Diversified Stocks As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with STERIS (NYSE:STE). Are Options Traders Betting on a Big Move in STERIS (STE) Stock? Investors need to pay close attention to STERIS (STE) stock based on the movements in the options market lately. AST Business Growth & Strategic Acquisitions Support STERIS Stock STE frequently engages in strategic acquisitions and joint ventures to optimize its portfolio of businesses. Is it the Right Time to Hold STERIS Stock in Your Portfolio? STE stays on investors' radars due to the strength of its Healthcare arm and strong rebound potential in the AST segment. 3 S&P 500 Stocks in Hot Water The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition. Firing on All Cylinders: CONMED (NYSE:CNMD) Q1 Earnings Lead the Way Looking back on surgical equipment & consumables - diversified stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including CONMED (NYSE:CNMD) and its peers. Deciphering Steris (STE) International Revenue Trends Examine Steris' (STE) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock. Steris PLC (STE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook Steris PLC (STE) reports robust financial performance with a 14% increase in adjusted EPS and outlines strategic plans for fiscal 2026 amidst tariff challenges. Why This Medical Equipment Stock Is Today’s S&P 500 Winner Steris beat quarter.y earnings and revenue expectations and got a price target boost from Morgan Stanley. Top Stock Movers Now: UnitedHealth Group, Walmart, Deere, and More U.S. equities were mixed at midday, with the Dow Jones Industrial Average and S&P 500 slightly higher and the Nasdaq marginally lower. STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket STERIS' fourth-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues. Here's What Key Metrics Tell Us About Steris (STE) Q4 Earnings Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. Steris (STE) Surpasses Q4 Earnings Estimates Steris (STE) delivered earnings and revenue surprises of 5.79% and 0.09%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock? Steris: Fiscal Q4 Earnings Snapshot The Dublin-based company said it had profit of $1.48 per share. Earnings, adjusted for non-recurring costs and to account for discontinued operations, came to $2.74 per share. The results exceeded Wall Street expectations. Steris Fiscal Fourth-Quarter 2025 Financial Results: Just the Numbers Medical equipment maker Steris on Wednesday afternoon reported fiscal fourth-quarter 2025 financial results. A summary of its key numbers is below. STERIS’s (NYSE:STE) Q1 Earnings Results: Revenue In Line With Expectations Medical equipment and services company Steris (NYSE:STE). met Wall Street’s revenue expectations in Q1 CY2025, with sales up 4.3% year on year to $1.48 billion. Its non-GAAP profit of $2.74 per share was 5.4% above analysts’ consensus estimates. Nuwellis, Inc. (NUWE) Reports Q1 Loss, Lags Revenue Estimates Nuwellis (NUWE) delivered earnings and revenue surprises of -53.33% and 23.84%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock? STERIS (STE) Q1 Earnings: What To Expect Medical equipment and services company Steris (NYSE:STE). will be reporting earnings tomorrow after the bell. Here’s what investors should know. Performance Overview Trailing total returns as of 5/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) Return 1S4.MU S&P 500 (^GSPC) YTD -13.78% +0.12% 1-Year +6.49% +10.98% 3-Year -16.04% +41.61%